Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Pfizer Ventures and Chiesi Ventures-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Chint, Sinopec, Intel, Wanxiang and Lenovo-backed process automation technology producer Supcon has priced an offering on Shanghai's Star Exchange.

The customer data analytics software operator is scheduled to go public on TSE Mothers Market, allowing Google, Mitsui and Mitsui Sumitomo Insurance to exit.

Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

The mobile app development platform is set to float on TSE’s Mothers Market in an initial public offering that would allow Globis, Itochu, Salesforce and Yahoo Japan to exit.

CapitalG-backed short-term accommodation provider Airbnb last raised financing at a $1bn pre-money valuation in April.

Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.

Pfizer Ventures is the largest individual shareholder in the cancer therapeutics developer, which has filed for a $100m offering.

Toyota and EDF-backed Nuvve, a developer of electric vehicle charging technology, is merging with Newborn Acquisition Corp to form a $202m business.